ABIVAX Société Anonyme Stock (OTCMKTS:AAVXF)

USA |PINK |USD

Price
$ 32.50
Change
0.00%
Today's Range
$ 32.50 - $ 32.50
52-Week Range
$ 21.22 - $ 43.97
Market Cap
$ 542.21M
Volume
0.00

About Abivax Société Anonyme (OTCMKTS:AAVXF)

(OTCMKTS:AAVXF) ABIVAX Société Anonyme discovers and optimizes drugs for the treatment of inflammatory diseases, infectious diseases, and cancer in France. Its principal products include ABX464 that is in Phase IIb clinical trials for the treatment of ulcerative colitis and Crohn's Disease, as well as for COVID-19; Phase IIa clinical trial for the treatment of rheumatoid arthritis diseases; and has completed Phase IIa clinical trial for the treatment of viral remission in patients with HIV. It also develops ABX 196, an immune enhancer candidate that is in Phase 1/2 clinical trials for the treatment of hepatocellular cancer. In addition, the company engages in the development of ABX 544, a drug candidate for the treatment of Ebola based on polyclonal antibodies; and research programs for the treatment of Dengue fever, influenza, and respiratory syncytial virus. ABIVAX Société Anonyme has license contracts with the French National Centre for Scientific Research, the University of Montpellier, and the Institut Curie. The company was founded in 2013 and is headquartered in Paris, France.
Show more

AAVXF Stock Price

Chart by TradingView

Statistics Highlights (OTCMKTS:AAVXF)

Shares Outstanding 16.68M Beta 1.14
Public Float 7.13M P/E Ratio -
% Short of Float - Dividend (Yield) -
Held by Insiders 5.85% Ex-Dividend Date
Held by Institutions 49.55% IPO Date -
Explore More on "Statistics" Section

AAVXF Financial Summary

|
Dec 20 Dec 19 Dec 18
Revenue $63.00K $23.00K $18.00K
EBITDA $-38.00M $-33.22M $-19.00M
Net Income $-37.55M $-30.63M $-15.82M
Total Assets $71.30M $51.73M $54.05M
Total Cash $29.30M $9.77M $13.00M
Total Debt $ $ $
Jun 21 Mar 21 Dec 20
Revenue $ $ $
EBITDA $ $ $
Net Income $ $ $
Total Assets $55.09M $ $71.30M
Total Cash $4.34M $ $29.30M
Total Debt $ $ $

(OTCMKTS:AAVXF) Stock Price FAQs

What is today's stock price of Abivax Société Anonyme (OTCMKTS:AAVXF)?

  • The current stock price of Abivax Société Anonyme (OTCMKTS:AAVXF) is $32.50.
  • Today AAVXF stock price opened at $32.50 after previous close of $32.50.
  • During the day, Abivax Société Anonyme stock quote has varied from a low of $32.50 to a high of $32.50.

What is Abivax Société Anonyme's 52-week change?

  • AAVXF 52-week high stock quote is $43.97, which is 35.30% above the current share price.
  • The Abivax Société Anonyme (OTCMKTS:AAVXF) 52-week low stock price is $21.22, which is 34.70% below the current share price.
  • Abivax Société Anonyme share price volatility (52-week beta) is 1.14.

Abivax Société Anonyme (OTCMKTS:AAVXF) FAQ

How Much is Abivax société anonyme Worth?

Abivax société anonyme's worth today based on market capitalisation is $542.21M

How much dividend does Abivax société anonyme Pay?

The current annualized dividend payout for AAVXF stock is $0.00, the dividend yield is 0.00% and the payout ratio is 0.00%.
View More Details on Abivax société anonyme's "Dividend" Section

What is Abivax société anonyme’s Price to Earning (PE) ratio?

AAVXF stock also has a Price to Sales (P/S) ratio of 82.56.

What is the Abivax société anonyme's ticker?

Abivax société anonyme trades on the OTC Markets stock market in USA under the ticker symbol "AAVXF". Abivax société anonyme’s stock symbol can also be displayed as "OTCMKTS:AAVXF".

Who are the owners of Abivax société anonyme?

Abivax société anonyme (OTCMKTS:AAVXF) is owned by 49.55% institutional shareholders and by 5.85% insiders. The rest is owned by the public.
Explore More Details on Abivax société anonyme's “Ownership” Section

Who are the key executives of Abivax société anonyme (AAVXF)?

Abivax société anonyme's key executive team includes the following managers:

  • Dr. Philippe Pouletty M.D., Ph.D., Founder & Chairman (1958)
  • Prof. Hartmut J. Ehrlich, Chief Exec. Officer (NA)
  • Mr. Didier Blondel, VP, CFO & Board Sec. (NA)
  • Ms. Raquel Lizarraga, Investor Relations Mang. (NA)
  • Ms. Regina Jehle, Director of Communication (NA)
  • Anne Pascard, HR Mang. (NA)
  • Mr. Pierre Courteille M.B.A., Chief Commercial Officer & VP of Bus. Devel. (NA)
  • Dr. Sophie Biguenet M.D., Chief Medical Officer (NA)
  • Dr. Alexandra Pearce, VP of Regulatory Affairs, Quality & Pharmaco-Vigilance (NA)
  • Mr. Paul Gineste, VP Clinical Operations (NA)

What is Abivax société anonyme’s Sector & Industry Classification?

Abivax société anonyme (OTCMKTS:AAVXF) is classified under the "Healthcare" sector and under the "Biotechnology" industry.

How many employees work for Abivax société anonyme?

Currently the number of employees working for Abivax société anonyme is 29.

Where are Abivax société anonyme's Headquarters?

Abivax société anonyme (OTCMKTS:AAVXF) is headquartered in France.

What are Abivax société anonyme's Address and Phone Number?

Abivax société anonyme’s mailing address is 5, rue de la Baume, Paris, France, 75008.
The company’s phone number is 33 1 53 83 08 41.

What is the official website for Abivax société anonyme?

Abivax société anonyme’s official website is http://www.abivax.com